ALICIA LIBBY: Open Payments
NPI 1538447081 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$820 in 36 payments from 20 companies in 2025. Trend: 2023 $535 · 2024 $802 · 2025 $820
Food & beverage: $820
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $116 |
| Daiichi Sankyo Inc. | 3 | $78 |
| ABBVIE INC. | 4 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| Geron Corporation | 2 | $58 |
| Astellas Pharma US Inc | 2 | $44 |
| ARRAY BIOPHARMA INC | 2 | $44 |
| TerSera Therapeutics LLC | 2 | $40 |
| Gilead Sciences, Inc. | 2 | $37 |
| BeiGene USA, Inc. | 1 | $33 |
Products named: KISQALI, RYTELO, BRUKINSA, DATROWAY, Trodelvy, EMRELIS, OPDIVO, LORBRENA.
Industry payments across NC — which companies pay providers there.
